Medical News |
- Retirement a sticking point for antihypertensive adherence
- Hyperglycemia heightens pneumonia risk in pediatric burns patients
- FENO and B-Eos complement each other as asthma biomarkers
- PSA mass ratio shows prognostic power in localized prostate cancer
- Metastatic site impacts survival in targeted RCC treatment
| Retirement a sticking point for antihypertensive adherence Posted: 06 Oct 2013 05:00 PM PDT Patients' adherence to their antihypertensive medication may decline when they retire from work, a study shows. |
| Hyperglycemia heightens pneumonia risk in pediatric burns patients Posted: 06 Oct 2013 05:00 PM PDT Research indicates that hyperglycemia puts pediatric burns patients at increased risk for pneumonia. |
| FENO and B-Eos complement each other as asthma biomarkers Posted: 06 Oct 2013 05:00 PM PDT Research indicates that fraction of exhaled nitric oxide and blood eosinophil count values can independently predict asthma diagnosis and attacks. |
| PSA mass ratio shows prognostic power in localized prostate cancer Posted: 06 Oct 2013 05:00 PM PDT Research shows that pathologic prostate-specific antigen mass ratio is a significant predictor for biochemical recurrence-free survival following radical prostatectomy for localized prostate cancer in patients with negative surgical resection margins. |
| Metastatic site impacts survival in targeted RCC treatment Posted: 06 Oct 2013 05:00 PM PDT Bone and liver metastases may have the heaviest impact on the survival of patients receiving targeted therapy for metastatic renal cell carcinoma, suggest data from the International Metastatic Renal Cell Carcinoma Database Consortium. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment